JPRN-UMIN000006141已完成未知
Comparative study of Infliximab monotherapy vs combined therapy with azathiopurine for inducing and maintaining clinical remission in steroid-dependent or -resistant ulcerative colitis - Comparative study of Infliximab monotherapy vs combined therapy with azathiopurine for inducing and maintaining clinical remission in steroid-dependent or -resistant ulcerative colitis
Department of Gastroenterology and Hepatology, Kyoto University Hospital0 个研究点目标入组 50 人开始时间: 2011年8月12日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 16years-old 至 75years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Patients who are required total colectomy or subtotal colectomy 2) Patients with severe active ulcerative colitis (CAI; more than 12) 3) Patients with malignancy 4) Patients with intestinal stenosis to cause intestinal obstruction 5) Patients with serious extraintestinal complication 6) Patients who are pregnant or desire pregnancy
研究者
相似试验
已完成
Unknown
Study of Infliximab Therapy for Multiple Treatment(included IVIG)-resistant Kawasaki DiseaseKawasaki DiseaseJPRN-jRCT1091220201Investigator-initiated Clinical Research(in-house)20
进行中（未招募）
不适用
Conventional Step-Up versus Infliximab Monotherapy in Patients with Active Moderate to Severe Ulcerative Colitis. A Randomized, Open Label, Prospective, Multicenter Study (Phase 3, Protocol No. P05553) - MUNIXActive Moderate to Severe Ulcerative ColitisMedDRA version: 14.1Level: LLTClassification code 10066678Term: Acute ulcerative colitisSystem Organ Class: 10017947 - Gastrointestinal disordersMedDRA version: 14.1Level: LLTClassification code 10033007Term: Other ulcerative colitisSystem Organ Class: 10017947 - Gastrointestinal disordersMedDRA version: 14.1Level: LLTClassification code 10045366Term: Ulcerative colitis, unspecifiedSystem Organ Class: 10017947 - Gastrointestinal disordersMedDRA version: 14.1Level: LLTClassification code 10045365Term: Ulcerative colitisSystem Organ Class: 10017947 - Gastrointestinal disordersEUCTR2009-010065-23-DEEssex Pharma GmbH
已完成
3 期
Efficacy of Infliximab comparing with Cyclophosphamide in refractory uveitis in Behcet’s diseasesBehcet's diseaseIRCT20180110038297N1Zanjan University of Medical Sciences20
进行中（未招募）
1 期
BackToBasic: The effect of Infliximab in patients with chronic low back pain and vertebral oedema on MRI scan.A randomized, double blind, placebo-controlled, multicenter trialon-specific chronic low back pain of more than 6 months duration. We will only investigate those who have vertebral end-plate chanages(Modic changes) on MRI.MedDRA version: 20.0Level: LLTClassification code 10008837Term: Chronic back painSystem Organ Class: 100000004859EUCTR2017-004861-29-NOFOU, Nevroklinikken, Oslo University Hospital -Ullevål126
已完成
不适用
Efficacy of Infliximab as a second Bio in patients with refractory rheumatoid arthritisRheumatoid arthritisJPRN-UMIN000020799Hokkaido University Hospital, Medicine II30